| Abstrakt: |
A recent study conducted at the University Regional Cariri Urca in Crato, Brazil, has investigated the potential benefits of naringenin, a citrus flavonoid, in the treatment of neonatal endotoxemia. Neonates are particularly vulnerable to endotoxemia due to their underdeveloped immune systems. The study found that naringenin, when administered to neonatal mice, reduced inflammation and oxidative damage caused by endotoxemia. The researchers concluded that naringenin could be a useful treatment for neonatal inflammatory injuries. [Extracted from the article] |
